CA
NZ
UK
AU
IND
US
Hidradenitis suppurativa was the most visible and commercially attractive indication for tibulizumab, a dual inhibitor of the IL-17 and BAFF pathways, and investors had treated it as the company's main near-term value driver. Removing it leaves Zura Bio with programs whose results are further …
Key HighlightsTG Therapeutics (NASDAQ:TGTX) reported third-quarter 2026 globalRevenueof USD 259.9 million on November 9, 2026, up about 60.7% from a year earlier and above the USD 245.5 million consensus.US net product revenue from BRIUMVI, its multiple sclerosis treatment, rose about 52% to USD 232.6 …
Key HighlightsDefinium Therapeutics (NASDAQ:DFTX) reported third-quarter 2026 results on November 9, 2026, holding about USD 241.2 million in cash and USD 805.7 million in short-term investments, roughly USD 1.05 billion combined.Its lead drug, DT120 ODT, a dissolvable form of lysergide, has met its primary …
Several measures pointed in the right direction. Ceva signed 10 intellectual property agreements in the quarter, including three with first-time customers and six for artificial intelligence applications. AI-related licensing reached a record, accounting for more than 35% of licensing revenue, a sign that its …
Key HighlightsZeta Global (NYSE:ZETA) reported third-quarter 2026Revenueof USD 492.7 million on November 9, 2026, up 46.1% from a year earlier and about 4.6% above the USD 471.2 million consensus.GAAPEarningswere USD 0.14 per share against expectations of USD 0.05, and adjusted EBITDA reached USD 121 …
Key HighlightsCsquare (NYSE:CSQR) rose about 6% in after-hours trading on November 9, 2026 after its secondQuarterly Reportas a public company, which showedRevenueof USD 302.3 million, up 25.6%, ahead of the roughly USD 289.8 million expected.Annualised bookings reached a record USD 66.1 million, up from …
Key HighlightsQuantum Computing Inc (NASDAQ:QUBT) reported third-quarter 2026Revenueof USD 9.5 million on November 9, 2026, above the roughly USD 7.6 million expected and up from USD 384,000 a year earlier.Quarterly revenue exceeded the company's total for the first half of 2026, which was USD …
Key HighlightsD-Wave Quantum (NYSE:QBTS) reports third-quarter 2026 results before the market opens on Tuesday, November 10, 2026, with a webcast at 8:00 a.m. ET, and Rigetti Computing (NASDAQ:RGTI) reports after the close with a call at 5:00 p.m. ET.Expectations for D-Wave point to a …
Key HighlightsExodus Movement (NYSEAMERICAN:EXOD) fell about 11% in after-hours trading on November 9, 2026 after reporting third-quarter 2026 results.Revenue rose 7% to USD 32.5 million, above the roughly USD 29.4 million expected, but the company swung to a net loss of USD 8.3 million …
Key HighlightsBakkt (NYSE:BKKT) reported third-quarter 2026Revenueof USD 149.2 million on November 9, 2026, down 62.9% from USD 402.2 million a year earlier and far below the USD 375.5 million expected.Net income attributable to the company was USD 14.3 million, or USD 0.31 per diluted …
Please wait processing your request...